Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhan Yu

Showing results (241-250 of 242) with videos related to

Pageof 25
Sort By:
You have reached the last page of results.This site can display upto 242 results.
Nature Medicine|July 16, 2025
The antibody-drug conjugate SHR-A1904 for targeting CLDN18.2 in advanced gastric or gastroesophageal junction cancer: a phase 1 trialDan-Yun Ruan, Hao-Xiang Wu, Su-Xia Luo, et al.
Biorxiv : the Preprint Server for Biology|August 20, 2025
Profibrotic monocyte-derived alveolar macrophages as a biomarker and therapeutic target in systemic sclerosis-associated interstitial lung diseaseNikolay S Markov, Anthony J Esposito, Karolina J Senkow, et al.
Pageof 25

Showing results (241-250 of 242) with videos related to

Sort By:
Pageof 25
You have reached the last page of results.This site can display upto 242 results.
Nature Medicine|July 16, 2025
The antibody-drug conjugate SHR-A1904 for targeting CLDN18.2 in advanced gastric or gastroesophageal junction cancer: a phase 1 trialDan-Yun Ruan, Hao-Xiang Wu, Su-Xia Luo, et al.
Biorxiv : the Preprint Server for Biology|August 20, 2025
Profibrotic monocyte-derived alveolar macrophages as a biomarker and therapeutic target in systemic sclerosis-associated interstitial lung diseaseNikolay S Markov, Anthony J Esposito, Karolina J Senkow, et al.
Pageof 25